EV/EBITDA:
-2.64-0.16(-6.45%)Summary
- As of today (July 27, 2025), NTLA EV/EBITDA is -2.64, with a fall of -0.16 (-6.45%) during the most recent trading session on July 25, 2025.
- Over the past year, NTLA EV/EBITDA has increased by +2.34 (+46.99%).
- NTLA EV/EBITDA is now -98.50% below its all-time high of -1.33.
Performance
NTLA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NTLA EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -6.5% | +6.4% | +6.4% |
| 1 m1 month | -42.7% | +42.5% | +42.2% |
| 3 m3 months | - | - | +63.6% |
| 6 m6 months | -21.7% | +22.9% | +23.7% |
| ytdytd | -14.3% | +15.8% | +16.6% |
| 1 y1 year | +47.0% | -45.3% | -48.5% |
| 5 y5 years | +61.4% | +78.2% | -29.0% |
NTLA EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -1.82 | -45.0% | -2.76 | +4.3% |
| 3 m | 3-month | -1.33 | -98.5% | -2.76 | +4.3% |
| 6 m | 6-month | -1.33 | -98.5% | -2.76 | +4.3% |
| 1 y | 1-year | -1.33 | -98.5% | -5.23 | +49.5% |
| 3 y | 3-year | -1.33 | -98.5% | -13.86 | +81.0% |
| 5 y | 5-year | -1.33 | -98.5% | -72.04 | +96.3% |
| alltime | all time | -1.33 | -98.5% | -72.04 | +96.3% |
NTLA EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.64(+14.3%) |
| 2024 | -2.31(-57.4%) |
| 2023 | -5.42(-7.7%) |
| 2022 | -5.87(-82.5%) |
| 2021 | -33.56(+25.6%) |
| Date | Value |
|---|---|
| 2020 | -26.73(+286.3%) |
| 2019 | -6.92(+11.6%) |
| 2018 | -6.20(-12.9%) |
| 2017 | -7.12(+11.1%) |
| 2016 | -6.41 |
FAQ
- What is Intellia Therapeutics, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Intellia Therapeutics, Inc.?
- What is NTLA EV/EBITDA year-to-date change?
- What is Intellia Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Intellia Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of NTLA is -2.64
What is the all time high EV/EBITDA for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high EV/EBITDA is -1.33
What is NTLA EV/EBITDA year-to-date change?
Intellia Therapeutics, Inc. EV/EBITDA has changed by -0.33 (-14.29%) since the beginning of the year
What is Intellia Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, NTLA EV/EBITDA has changed by +2.34 (+46.99%)